Introduction
The Thy-l gene is a member of the lg superfamily of genes (Williams, 1985) and is expressed in many different cell types. The cell-surface glycoprotein (17 kd) is anchored to the cell membrane via a glycophospholipid (Williams and Gagnon, 1982; Low and Kincade, 1985; Tse et al., 1985) , a property shared by an increasing number of other cell-surface proteins (for review, see Low et al., 1986) . The antigen has a very complicated expression pattern, but was first characterized as a murine T lymphocyte-specific antigen (Reif and Allen, 1964) . In the mouse it is also found on lymphocyte precursors, including pluripotential hematopoietic stem cells (flitter et al., 1980; Muller-Sieburg et al., 1986) , fibroblasts, and most neurons in the central nervous system (see review, Morris, 1985) . In humans, Thy-l is also expressed in neurons and in populations of early T and B cells (flitter et al., 1983) ; however, it is absent from T lymphocytes (Ritter et al., 1983) and is present at high levels in kidney (Dalchau and Fabre, 1979) . The rat shows a mixture of the human and mouse patterns of expression; it is expressed in brain, in early T and B cells, and in the kidney mesangial cells (Morris, 1985) .
The function of the Thy-l antigen is not known but it has been postulated to be involved in cell-cell recognition (Williams and Gagnon, 1982; Williams, 1985) . Certainly Thy-l-specific antibodies can stimulate intracellular calcium levels and cause proliferation in mouse T cells and in transfected 6 cells (Kroczek et al., 1986a (Kroczek et al., , 1986b Gunter, 1984) . This has led to the suggestion that in T cells Thy-l has a proliferative function that is antigen-independent (Kroczek et al., 1986b) , taking place via the T%de-pendent pathway (Gunter et al., 1987) . However, if Thy-l has a proliferative function in hematopoietic cells in general, it would be in very early pre-T cells, since it is not present in mature T cells in rat and in humans. In neurons,
Thy-l only appears well after proliferation lhas ceased, so that its role on these cells would not appear to be related to cell division . The human and mouse Thy-l genes hawe been cloned and characterized (Giguere et al., 1985; lngraham and Evans, 1986; lngraham et al., 1986; Seki et al., 1985) . The mouse gene is possibly expressed from ltwo promoters, resulting in different untranslated 5' leader sequences (Giguere et al., 1985; lngraham et al., 1986) . The promoter regions are not tissue-specific, lack a TATA box, and are contained in a methylation-free island (Giguere et al., 1985; lngraham et al., 1986; Kolsto et al., 1986) . Several tissue-specific extragenic and intragenic sequences are required for efficient and cell-type-specific expression (Giguere et al., 1985; lngraham arid Evans, 1986; Kollias et al., 1987) . We have shown previously that a mouse-human Thy-l gene can be expressed at high levels in nerve cells and thymocytes in transgenic mice (Kollias et al., 1987) , although the gene was not expressed in peripheral T cells. To define the &-acting sequencles that are involved in the tissue-specific expression of the Thy-l gene, we introduced a number of mouse-human Thy-l hybrid genes into the germline of mice. Analysis of the expression patterns of the Thy-l transgenes showed consistent expression in the mouse kidney tissues, normally negative for Thy-l in the mouse but positive in humans. We report that this inappropriate expression of Thy-l leads to either kidney malfunction or kidney proliferative disorders and malfunction.
Results
Murine Thy-l Expression in the Glomerulus Causes Proteinuria in the Transgenic Mice The constructs shown in Figure 1 were injected into fertilized (CBA x C57BI) Fl mouse eggs (Thy-l.2 background) to obtain Thy-1.1, or human Thy-l transgenic mice. The first construct (T) contains the murine Thy-l.1 gene in which the 3' untranslated region has been replaced with a similar region from the human Thy-l giente. The mature Pt'Otein resulting from this transgene is completely Thy-l.1 and can be distinguished from its allelic form, the endogenous Thy-1.2, by using monoclonal antibodies (Williams and Gagnon, 1982) . This construct does not lead to correct expression in mature T lymphocytes (Kollias et 1987), so a second construct (mhT) containing additional upstream sequences from the murine gene was made ( Figure 1 ). The third construct (hT) contains the normal murine 3' untranslated region, but the central part of the gene coding for the mature protein has been replaced with the homologous part of the human gene. Injections of the T construct resulted in four transgenic mice, T6, T9, Tll, and T12. TG.had a very high level of expression of the transgene and died in infancy; T9 had a low level of expression and could be bred to a homozygous animal with similar expression patterns to Tll and T12. Tll and T12 both had multiple copies of the transgene and expressed approximately six to ten times the normal level of Thy-l in the brain. The expression in lymphoid cells was abnormal (Kollias et al., 1987) and will be considered further elsewhere (Kollias, unpublished data) . Surprisingly, the presence of the human 3'end in the Thy-l.1 transgene caused expression in the kidneys of all these animals. Additional sequences at the 5' end (mhT; Figure 1 ) did not change that pattern, and another transgenic animal (mhT4) with high expression levels in the kidney was obtained. Three other healthy (mhT) animals had nearly lo-fold lower levels of expression in the kidney on the same cell type. These animals did not show any abnormalities and will not be considered further. When transgene mRNA levels of Tll, T12, and mhT4 are compared with each other ( Figure  2a ), it is clear that these animals express the transgene and the endogenous gene in brain (Tl2 > Tll > mhT4), but only the transgene in kidney. Neither gene is expressed in liver ( Figure 2a ). All T12 mice and the first generation of mhT4 developed proteinuria after the first month of life, which culminates in severe kidney sclerosis. Different offspring of T12 were analyzed at different times during development to determine levels of Thy-l mRNA in the kidney, and of proteinuria (Figures 2b, 2~ ). Between 30 and 36 days, which is the time of onset of the proteinuria (urine analysis, Figure 2c ), there is an increase in transgenic mRNA in the kidney. By the time the animals develop a kidney sclerosis the apparent level of transgene mRNA has decreased, because of the destruction of Thy-l-expressing cells (see below). At the same time, the level of endogenous Thy-l.2 increases above background, because of T lymphocyte infiltration, Normal mouse kidney is immunohistochemically Thy-lnegative (not shown; see also Morris and Ritter, 1980) , so the very small amount of Thy-l, which can be measured by radioimmunoassay, arises either from a generalized, very low level of antigen expression, or from T lymphocytes in the blood vessels. In contrast, all the T12, Tll, and mhT4 mice examined contained an identical very heavy distribution of Thy-l in the glomeruli (Figure 3a ) on podocytes ( Figure 3e ). Endogenous Thy-l.2 remained undetectable immunohistochemically. Expression of the transgene in podocytes was found in T12 mice at 11 days (the earliest age investigated) and persisted through the onset and course of proteinuria development (Figures 3a, 3c, 3d) . None of the other cell types in the kidney, including the mesangial cells of the glomeruli, had detectable transgenie Thy-l.1 associated with them during this period.
The kidneys of the 20-and 30-day-old mice did not differ histologically or ultrastructurally from those of their littermates (Figure 4a ). At 36 days, T12 transgenic mice showed minor degrees of (podocyte) foot process swelling ( Figure 4b ) and a slight mesangial deposition of C3, IgM, and IgG with the same distribution as that found in the littermates (not shown). With increasing severity of proteinuria (Figure 2c ), the animals showed extensive glomerular and tubular changes (Figures 3a, 3c, 3d; Figures 4c, 4d) . The tubules became dilated (Figures 3c, 3d ) and were found to contain protein casts. The glomerular change is best summarized as a severe segmental sclerosis. Changes varied a great deal from glomerulus to glomerulus (Figures 4c, 4d) , with some glomeruli showing areas of lobular collapse and an increase of basement membrane-like material ( Figure 4~ ). In others, electron dense deposits (Figure 4d) , mostly in the mesangium but also occasionally as large subendothelial accumulations, were a prominent feature. Occasional foci of mesangial proliferation were seen. Extracapillary proliferation (crescents) and subepithelial deposits were not seen. In these severely damaged glomeruli there are marked podocyte abnormalities with foot process swelling and vacuolation ( Figure 4d ). Only then did the glomeruli show heavy deposits of IgG, IgM, and C3 in the mesangial regions.
The possibility that antiThy-1.1 antibodies might be a significant component of the immune response evident in the damaged kidneys was investigated using a sensitive radioimmunoassay. Serum from four T12 homozygous mice aged 8 weeks, which showed heavy proteinuria and severe kidney damage, was assayed for antibodies binding to both Thy-l.1 and Thy-l.2 thymocytes. To avoid any masking of anti-Thy-l.1 antibodies by immune complex formation, aliquots of each serum were diluted in 0.5 M acetic acid to dissociate such complexes prior to incubation with thymocytes. No difference was found between such acid-treated serum and aliquots diluted in PBS. Two transgenic mice had titers on the Thy-l.l-type thymocytes that were indistinguishable from their littermates, or from their serum titered on Thy-l.2 thymocytes. The other two transgenic mice had the same titer as the rest, but at the lowest dilutions showed slightly higher binding to the Thyl.l-type thymocytes. By comparison with control antiThy-1.1 antibodies, this was equivalent to 0.04 ug of antibody per ml (approximately 2.10T4% of total serum lg). Serum from four heterozygotic T12 mice and their littermates at 28 days of age again showed no differences.
Expression of Human Thy-l in Murine Kidney induces Proliferative Abnormalities of Proximal Tubular Epithelium injection of the hT construct ( Figure 1 ) resulted in ten positive transgenic mice. Three of these, hT27, hT6, and hT16, were alive and apparently normal, and hT27 was analyzed in detail. Two of the mice, hT1 and hT8, died before they could be analyzed; the remaining five mice, hT10, hT13, hTd1, hTd4, and hTd5, also died, but could be analyzed in detail for the expression of Thy-l. Sl nuclease analysis ( Figure 5 ), using probes for the human Thy-l gene and the endogenous Thy-l.2 gene, shows that high levels of expression of the transgene Thy-l are found in the brain and kidney, while the endogenous Thy-l RNA is found only in the brain. Again, liver does not show expression of either gene. By radioimmunoassay the kidneys were discovered to express a level of human Thy-l comparable to that expressed by normal human brain (Table 1) . hT10, hT13, hTd1, hTd4, and hTd5 all developed a cystic neoplasm of Thy-lpositive cells, while hT27 has no apparent abnormalities. This is not due to a lack of transcription of the transgene, since hT27 expressed high levels of intact mRNA ( Figure  5 and Northern blots, not shown), but probably to a secondary mutation in the gene, since very little human Thy-l could be detected immunohistochemically.
The kidneys of hT10 and hT13 were analyzed histologically and immunohistochemically. Both showed neoplasms derived from the proximal tubules through an intermediate in situ tumor. Many tubules show cystic dilation (Figure 3f ). In some, usually larger, dilated tubules, the epithelium maintains a monolayer and is Thy-l-negative (Figure 3h) . In other tubules, the epithelia have very heavy Thy-l deposits at their luminal surface (Figures 3h, 3i) , with cells often showing an unusual degree of nuclear variability, an increase in nuclear size, ancl a high mitotic rate, leading to closure of the tubules (Figure 3h ). In contrast to the earlier mice containing the T and mhT constructs, podocytes in hTl0 and hT13 kidneys were Thyl-negative (Figure 39) . However, the Thy-+positive in situ lesions often extended into glomeruli, which confirmed the proximal tubular origin of the lesion. In addition, analysis of brain tissue of hT13 revealed a papilllomatous neoplasm of the choroid plexus ( Figure 6 ) that filled the third and fourth ventricles. The cells showed cytological atypia, which we have not yet analyzed in detail.
Tubular Epithelium Expressing Thy-l Is Immortalized in Culture Part of an hT10 kidney was put into culture,, where a number of morphologically different cell types (Figure 7a ) proliferated rapidly. Cell lines were derived by repeated (two to four) sequences of limiting dilution cloning. Control kidney suspensions cultured at the same tilne proliferated more slowly and stopped growing completely after 10 weeks of continuous culture. We could shalw that the htl0 neoplastic cells are of epithelial origin by the following criteria: all cell lines were positive for cytokeratin (e.g., Figure 79, 7h) and for the monoclonal 4Fl (Figure 7f ) to thymus cortical epithelia, which also reacts with kidney tubular epithelia in vivo (Ritter, unpublished data) . Moreover, all were negative (or very low) for endogenous Thy-l .2, unlike fibroblasts (Stern, 1973) . Interestingly, an extensive range of cell types could be isolated by using different criteria: morphology (Figures 7b-7e ), proliferation rate (18-48 hr), fibronectin expression (some exclusively cellular, others incorporating it into the extracellular matrix; Figures 7i, 7j) , and the presence of the enzyme D amino acid oxidase. This enzyme is present in tubular epithelium but not in fibroblasts (Gilbert and Migeon, 1975) , and can be selected for in media that contain the B form of valine only. Although identical to each other by the criteria mentioned above, both resistant and sensitive cell lines were isolated. The uncloned cells had abundant human Thy-l mRNA ( Figure 2 ) and high Thy-l levels, as measured by radioimmunoassay (Table 1 ). Each of the 36 different cell lines that have been derived expresses human Thy-l, in levels ranging from 15%-90% of the level found in normal human brain (Table 1) . Neither the original luncloned cells nor any of the lines (six to date) give transplantable tumors when introduced into the peritoneal cavity or subcutaneously in nude mice.
Discussion
Two purposes can be served by the production of transgenie mice: the elucidation of tissue-specific regulatory elements for the gene under study and the analysis of the biological role of the gene product. Both aqpects are illustrated by our study. By constructing human--mouse hybrid Thy-l genes, we exploited the extensive differences in tissue-specific expression that occur between these two species. In particular, Thy-l is virtually absent from murine kidney (Reif and Allen, 1964; Morris anld Ritter, 1980 but is present at substantial levels (Dalchau and Fabre, the kidney (Kollias et al., 1987) , it seemed opportune to ex-1979) in human kidney. Since the T construct introduced amine the effect of further human-mouse hybrid Thy-l into transgenic mice gave high levels of Thy-l.1 product in genes on kidney expression and function.
RNA in the kidney is easily visible at higher exposures (see Figure 2b ). (b) Expression of T and mhT transgenic mRNA in rnouse kidney tissues at several points in development. Br, normal Fi mouse brain RNA. 20, 30, and 36 denotes postnatal development in days. "'W signifies adult (7. to lo-week-old animals). The sequence p+p-+p+s denotes otherwise healthy T12 animals with increasing levels of proteinuria advancing to very sick (S) adult animals (see also Figure 2~ ). The Sl analysis was carried out as in (a) except that the Hinfl probe for the Thy-l.2 RNA was used (see Experimental Procedures). (c) SDS-polyacrylamide gels showing development of proteinuria in T12 transgenic mice (Figure 2b ). Urine (5 ~1) was eleo trophoresed under nonreducing conditions, and the gels were stained with Coomassie blue. 30,36, and A are as described in Figure 2b . Molecular weight markers were reduced samples of ovalbumin (43K), bovine serum albumin (68K), human transferrin (76Q, and rabbit muscle phosphorylase B (9X). We have shown that both the T and mhT constructs give high levels of transgenic Thy-l expression in glomerular podocytes. Because the expression of endogenous Thy-1.2 remains unaffected and the ectopic expression in podocytes is observed in all Thy-l-expressing mice carrying the T or mhT constructs (but not the mouse Thy-l gene only or the hT construct), we conclude that the human Thy-1 gene 3'segment carries a cis-acting element capable of contributing to expression in podocytes. On the other hand, the hT construct that contains a different segment of the human Thy-l gene led to high expression of the transgene in the kidney proximal tubular epithelium. Similarly, we conclude that the central part of the human Thy-l gene contains c&acting sequences that, in combination with the other regulatory elements, direct Thy-l expression in proximal tubular epithelium. It should be noted that neither construct caused Thy-l expression on the mesangial cells, on which it is found in the rat (Morris and flitter, 1980 ; for review, see Crawford and Barton, 1986) .
Both patterns of ectopic kidney expression produced distinct physiological effects. Podocyte expression of the T and mhT constructs, at a sufficiently high level (T12, Til, mhT4), caused proteinuria in two of the three mouse lines (T12, mhT4). These express the highest levels of the T construct in their kidneys (Table l) , although the levels of mRNA in mhT4 appear to be lower than those in Tll in Figure 2b . This is because the kidneys of this animal were in an advanced diseased state and show the same pattern of expression as that observed for the T12 adult sick animals (Figure 2b ), i.e., low transgene but high endogenous Thy-l expression. Interestingly, the onset of proteinuria in T12 is associated with a rise in transgene expres- Figure 7 ) were hybridized to a 960 nucleotide BstEll-Apal human Thy-i probe (Pr). Normal transcription of the hT transgene produces an mRNA that protects 320 nucleotides of the above probe from Sl digestion (hT). Sizes were estimated from an end-labeled Hinfl digest of pBR322 DNA. After longer exposures of the autoradiograph (not shown), the positive control lane NE gave a detectable signal at the expected size. All other negative lanes remained negative. Bottom: The same as top panel but with an 600 nucleotide BstEll-Apal mouse fragment as a probe (Pr). In this case only the endogenous Thy-1.2 mRNA will protect 320 nucleotides of the probe from Sl nuclease digestion (mT).
sion in the kidney (Figure 2b ). This is not caused by podocyte proliferation or expression of Thy-i on other cell types. Therefore, this suggests that when the Thy-l on the podocytes in T12 and mhT4 reaches a certain level, their function in maintaining the filtration barrier of the basement membrane is perturbed, and proteinuria results.
There are several circumStances in other animals where proteinuria follows either a toxic insult or a metabolic abnormality and where the podocyte seems to be the affected cell. In humans, the spontaneous metabolic abnormality in Fabry's disease results in the accumulation of ceramide trihexoside in many cells in the body, and the podocyte is prominently affected. Proteinuria is present and the glomeruli develop focal and segmental hyalinosis or sclerosis (Heptinstall, 1978) . In the rat, the podocytes appear especially sensitive to purine aminonucleoside both in vitro (Fishman and Karnovsky, 1985) and in vivo. In the intact animal, administration of the drug is followed after a few days by the development of proteinuria: the podocytes show striking ultrastructural changes (Caulfield et al., 1976) . Subsequently, there is the development of mesangial hypercellularity, and animals that survive the acute phase of the disease subsequently develop widespread glomerulosclerosis (Diamond and Karnovsky, 1986) . Interestingly, administration of anti-thymocyte, or antiThy-l, antibodies in both humans and rats can also lead to glomerulonephritis (Cunningham et al., 1987; Ragchus et al., 1986; lshizaki et al., 1986) . However, 'certainly in the case of anti-Thy-l antibodies in the rat, ,the mesangial cells, rather than the podocytes, constitute the primary target tissue, and the disease is immune-related (Bagthus et al., 1986) . In our case, there is na evidence for immune involvement during the onset of proteeinuria, which appears to be a direct result of ectopic Thy-l expression. In the case of the hT constructs, proteinuria also characterized the development of a renal abnormality, but in this case it is probably the result of glomerular disruption caused by invasion of neoplastic proximal tubular epithelium. The primary lesion appeared to be the uncontrolled proliferation of these epithelial cells, giving rise to a cystic qeoplasm. The cell lines derived from the hT10 kidney appear to be all epithelial, as expected from this neoplasm, yet they show several differences in morphology ( Figure  7) . Moreover, most proximal tubules in all hT animals develop this neoplasm, and it seems therefore highly unlikely that the neoplasm is the result of a single cell clone in each animal, but rather of a population of cells. These give rise to different, continually proliferating cell lines in culture, each containing high levels of the transgenic Thy-1, which suggests an a priori case for the involvement of Thy-l in proliferation. Whether the proliferation is the result of a blockage of terminal differentiation of tubular epithelial cells by the expression of Thy-l on their cell surface, or that Thy-l antigen is the primary stimulator for proliferation by an autocrine-type mechanism as, for example, observed for some oncogenes, is not yet clear. However, the fact that all the cells that proliferate in culture express Thy-l suggests that the latter might be the case.
The occurrence of a neoplasm of the choroid plexus epithelium in one hT animal is particularly intriguing, given the similarity of this tissue to the kidney proximal tubules. Both tissues are an epithelial monolayer involved in the selective interchange of molecules to and from the bloodstream.
Indication of a role for Thy-l in cellular proliferation is more advanced in the lymphoid system, where anti-Thy-l antibodies, acting through the T3/Ti system on intracellular Ca2+ levels, cause proliferation of T lymphocytes (Kroczek et al., 1988b; Gunter et al., 1987) . It will be interesting to determine whether a similar pathway is used in the proximal tubular epithelium, and why high levels of expression of Thy-l fail to reactivate podocytes.
Experimental Pmcedums
Hybrid Gene Construction and Pmduction of Transgenic Mice The hybrid gene named T (Figure 1 ) was constructed by fusion of a 5.7 kb EcoRI-Apal mouse Thy-l.1 gene fragment containing the first four exons (including exons la and lb) and part of exon IV to a 3.4 kb Apal-EcoRI human Thy-l DNA sequence containing the remaining noncoding part of exon IV plus 3'human flanking sequence. The mhT hybrid gene was constructed by the addition to the T hybrid gene of a 1.3 kb Sall-EcoRI fragment derived from the Yupstream flanking region of the mouse Thy-l.1 gene. Finally, the EcoRI-EcoRI fragment containing the mouse Thy-l.2 gene was the basis for the construction of the hT hybrid gene, which was formed by replacement of a 0.8 kb BstEll-Apal fragment containing the coding part of exons Ill and IV with the homologous 0.96 kb BstEll-Apal human Thy-l gene fragment.
Linear DNA fragments were excised from vector sequences with the appropriate restriction enzymes, separated on low melting agarose gels, isolated, and used for microinjection. F2 hybrid mouse zygotes of CBA x C57Bl110 parents were isolated, and pronuclei were injected with a solution containing approximately 2 Kg/ml DNA fragments in TE buffer (10 mM Tris, pH 7.5; 0.1 mM EDTA). Eggs surviving the microinjection were transferred into the oviducts of recipient pseudopregnant females (for review, see Brinster et al., 1985) . Ten days after birth, pups were analyzed for the presence of intact injected DNA by Southern blot analysis of tail genomic DNA (Southern, 1975) .
Purification
and Analysis of RNA from Mouse Tissues Whole tissues were washed in PBS, and cells were lysed by homogenization in 5-10 ml of ice-cold 3 M LiCI, 6 M urea (Auffray and Rougeon, 1980) . The homogenate was mixed overnight at 4OC and the next morn- ing RNA was pelleted. After a brief wash in 2 ml of the same ice-cold LiCI-urea solution and recentrifugation, the RNA pellet was resuspended in 500 ul of a 10 mM Tris (pH 7.6) 1 mM EDTA, 0.5% SDS solution followed by phenol/chloroform extraction and ethanol precipitation. Concentrations were determined from absorbance at 260 nm and confirmed by electrophoresis on 2% agarose gels. The latter also showed that the RNA preparations were undegraded. $1 nuclease analysis of Thy-l-specific mRNA was performed as described elsewhere (Kollias et al., 1967) . RNA was hybridized to a 686 nucleotide Bamlil (Figure 2a) or 340 nucleotide Hinfl (Figure 2b ) 3' end-labeled probe from the 3'end of the Thy-l.2 gene and a 950 nucleotide NcolBglll 3' end-labeled probe from the 3' end of the human Thy-l gene (Pr). Normally, transcription from the endogenous, Thy-l.2 gene produces an mRNA that protects a probe fragment of 115 or 210 nucleotides from Sl nuclease digestion (mT). Normal transcription from the T or mhT transgenes produces a major mRNA that protects a probe fragment of 165 nucleotides from Sl digestion (hT). A minor band at 400 nucleotides represents a second poly(A) addition site for the transgenie mRNA (hT). Sizes were estimated from an end-labeled Hinfl digest of pBR322 DNA (lane M).
lmmunohistochemical
and Histological Analysis One kidney from each animal was cut transversely into four sections, one of which was snap-frozen by immersion in isopentane/liquid nitrogen, sectioned on a cryostat, and analyzed for deposition of mouse IgG, IgM, and third component of complement (fluorescein-conjugated sheep anti-mouse IgM and rhodamine-conjugated rabbit anti-mouse IgG were from Miles; goat anti-mouse C3 was from Nordic). Another segment was fixed by immersion in formalin and processed through paraffin wax for histological examination; a third segment was fixed in 1% glutaraldehydeM% paraformaldehyde in 100 mM phosphate buffer (pH 7.4), osmicated, embedded in Epon, and stained in lead citrate before examination in the electron microscope. The final segment was fixed in 95% ethanol/5% acetic acid and embedded in polyester wax, and 5 urn sections were stained for Thy-1.1, Thy-1.:2, or human Thy-l. These different forms of Thy-i were detected by using monoclonal antibodies OX7 (Mason and Williams, 1960) 30H-12 (Ledbetter and Herzenberg, 1979 ) and F1542-1-5 (Dalchau and Fabre, 1979) , respectively. In immunohistochemistry these were routinely vilsualized with a horseradish peroxidase-conjugated second antibody, either our own affinity-purified rabbit F(ab)a anti-mouse IgG (Kollias et ial., 1967) or, for the rat monoclonal 30H-12, a rabbit anti-rat IgG (DAKG) that was first absorbed with mouse serum to remove antibodies cross-reacting with endogenous lg in the capillaries, and in damagecl kidneys, the mesangium. Detection of the transgene products, whether Thy-1.l or human Thy-l, was done with mouse monoclonals, and reaction of the second antibody was endogenous lg was potentially a problem. However, the concentration of both transgenic products was so high in kidney that simply using the second antibody at a high dilution (2 uglml) enabled visualization of the transgenic Thy-l with minimal detection of endogenous lg. Use of our normal concentration of second antibody (20 ug/ml) gave more intense staining of the transgenic product, and also endogenous lg labeling, but revealed no further cell types expressing the transgene. In addition, for detecting the T and mM constructs, we used a directly horseradish peroxidase-conjugated F(ab')s of OX7 antibody, and obtained the same pattern of specific labeling as found with the indirect conjugates.
Radioimmunoassays
These were done as previously described for Thy-l.1 and Thy-i.2 (Kollias et al., 1967) . Human Thy-l was measured by the same method, using 0.25 ug/ml of F15-42-1-5 IgG as the first antibody, and residual antibody activity remaining after absorption was back-titered onto 100 pg of human brain membranes. Homogenates of adult AKR, CBA x C57B, or human brain were used as standards in measuring Thy-1.1, Thy-1.2, and human Thy-l, respectively. Neither mouse brain or kidney, or human brain, gave any absorption of the inappropriate monoclonal antibodies, even at tissue concentrations up to 1600 times greater than that giving absorption of the correct antibody. Similarly, in immunohistochemistry, no cross-reaction of antibodies with1 inappropriate tissue (e.g., OX7 or F15-42-1-5 with nontransgenic CE3A x C57BI littermate kidney) was seen.
